HRMY Financial Statements

Balance sheet, income statement, cash flow, and dividends for Harmony Biosciences Holdings Inc (HRMY).


$1.96B Market Cap.

As of 02/25/2025 5:00 PM ET (MRY) • Disclaimer

HRMY Market Cap. (MRY)


HRMY Shares Outstanding (MRY)


HRMY Assets (MRY)


Total Assets

$999.20M

Total Liabilities

$340.05M

Total Investments

$123.33M

HRMY Income (MRY)


Revenue

$714.73M

Net Income

$145.49M

Operating Expense

$367.09M

HRMY Cash Flow (MRY)


CF Operations

$219.82M

CF Investing

-$67.48M

CF Financing

-$11.00M

HRMY Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

HRMY Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$999,200,000 (23.14%)

$811,448,000 (20.42%)

$673,870,000 (55.47%)

$433,443,000 (1.49%)

Assets Current

$579,252,000 (28.42%)

$451,070,000 (12.69%)

$400,285,000 (40.73%)

$284,439,000 (8.20%)

Assets Non-Current

$419,948,000 (16.53%)

$360,378,000 (31.72%)

$273,585,000 (83.61%)

$149,004,000 (-9.25%)

Goodwill & Intangible Assets

$113,263,000 (-17.39%)

$137,108,000 (-14.81%)

$160,953,000 (11.84%)

$143,919,000 (-11.35%)

Shareholders Equity

$659,155,000 (41.15%)

$466,992,000 (15.93%)

$402,838,000 (115.99%)

$186,507,000 (91.92%)

Property Plant & Equipment Net

$1,257,000 (238.81%)

$371,000 (-35.25%)

$573,000 (-30.12%)

$820,000 (-12.58%)

Cash & Equivalents

$453,001,000 (45.35%)

$311,660,000 (27.84%)

$243,784,000 (4.04%)

$234,309,000 (2.48%)

Accumulated Other Comprehensive Income

$66,000 (3200.00%)

$2,000 (101.32%)

-$151,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$123,329,000 (7.96%)

$114,239,000 (11.29%)

$102,649,000 (13586.53%)

$750,000 (0.00%)

Investments Current

$14,185,000 (-66.06%)

$41,800,000 (-47.31%)

$79,331,000 (0%)

$0 (0%)

Investments Non-Current

$109,144,000 (50.67%)

$72,439,000 (210.66%)

$23,318,000 (3009.07%)

$750,000 (0.00%)

Inventory

$7,198,000 (34.22%)

$5,363,000 (24.81%)

$4,297,000 (-3.05%)

$4,432,000 (15.93%)

Trade & Non-Trade Receivables

$83,033,000 (11.99%)

$74,140,000 (35.44%)

$54,740,000 (57.10%)

$34,843,000 (57.12%)

Trade & Non-Trade Payables

$13,744,000 (-22.48%)

$17,730,000 (368.30%)

$3,786,000 (278.22%)

$1,001,000 (-60.84%)

Accumulated Retained Earnings (Deficit)

$2,216,000 (101.55%)

-$143,277,000 (47.35%)

-$272,130,000 (40.01%)

-$453,598,000 (7.09%)

Tax Assets

$190,398,000 (32.07%)

$144,162,000 (67.74%)

$85,943,000 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$179,266,000 (-7.39%)

$193,566,000 (1.00%)

$191,647,000 (-0.18%)

$191,984,000 (-1.17%)

Debt Current

$16,250,000 (8.33%)

$15,000,000 (650.00%)

$2,000,000 (0.00%)

$2,000,000 (0%)

Debt Non-Current

$163,016,000 (-8.71%)

$178,566,000 (-5.84%)

$189,647,000 (-0.18%)

$189,984,000 (-2.20%)

Total Liabilities

$340,045,000 (-1.28%)

$344,456,000 (27.09%)

$271,032,000 (9.76%)

$246,936,000 (-25.15%)

Liabilities Current

$175,082,000 (6.90%)

$163,781,000 (107.62%)

$78,884,000 (46.69%)

$53,775,000 (-60.03%)

Liabilities Non-Current

$164,963,000 (-8.70%)

$180,675,000 (-5.97%)

$192,148,000 (-0.52%)

$193,161,000 (-1.12%)

HRMY Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$714,734,000 (22.80%)

$582,022,000 (32.93%)

$437,855,000 (43.35%)

$305,440,000 (91.21%)

Cost of Revenue

$156,815,000 (29.35%)

$121,236,000 (45.23%)

$83,481,000 (50.37%)

$55,518,000 (100.15%)

Selling General & Administrative Expense

$221,268,000 (14.83%)

$192,693,000 (18.00%)

$163,302,000 (23.69%)

$132,027,000 (38.15%)

Research & Development Expense

$145,825,000 (91.72%)

$76,063,000 (7.30%)

$70,886,000 (133.43%)

$30,367,000 (56.14%)

Operating Expenses

$367,093,000 (36.59%)

$268,756,000 (14.76%)

$234,188,000 (44.21%)

$162,394,000 (41.19%)

Interest Expense

$17,496,000 (-26.35%)

$23,757,000 (51.62%)

$15,669,000 (-34.63%)

$23,970,000 (-15.06%)

Income Tax Expense

$46,311,000 (3.97%)

$44,543,000 (158.01%)

-$76,782,000 (-2812.19%)

$2,831,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$145,493,000 (12.91%)

$128,853,000 (-28.99%)

$181,468,000 (424.52%)

$34,597,000 (193.65%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$145,493,000 (12.91%)

$128,853,000 (-28.99%)

$181,468,000 (424.52%)

$34,597,000 (193.65%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$145,493,000 (12.91%)

$128,853,000 (-28.99%)

$181,468,000 (424.52%)

$34,597,000 (154.19%)

Weighted Average Shares

$56,885,455 (-4.35%)

$59,469,648 (0.50%)

$59,173,121 (2.85%)

$57,531,540 (123.23%)

Weighted Average Shares Diluted

$57,869,915 (-4.15%)

$60,372,397 (-1.19%)

$61,097,045 (3.20%)

$59,205,213 (129.72%)

Earning Before Interest & Taxes (EBIT)

$209,300,000 (6.16%)

$197,153,000 (63.81%)

$120,355,000 (96.02%)

$61,398,000 (803.78%)

Gross Profit

$557,919,000 (21.08%)

$460,786,000 (30.03%)

$354,374,000 (41.79%)

$249,922,000 (89.33%)

Operating Income

$190,826,000 (-0.63%)

$192,030,000 (59.78%)

$120,186,000 (37.31%)

$87,528,000 (415.29%)

HRMY Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$67,484,000 (-45.32%)

-$46,439,000 (67.26%)

-$141,832,000 (-41.41%)

-$100,298,000 (-4909.89%)

Net Cash Flow from Financing

-$10,996,000 (89.58%)

-$105,552,000 (-1642.93%)

$6,841,000 (-7.79%)

$7,419,000 (-96.45%)

Net Cash Flow from Operations

$219,821,000 (0.20%)

$219,387,000 (51.86%)

$144,466,000 (46.58%)

$98,557,000 (3401.74%)

Net Cash Flow / Change in Cash & Cash Equivalents

$141,341,000 (109.72%)

$67,396,000 (611.30%)

$9,475,000 (66.87%)

$5,678,000 (-97.22%)

Net Cash Flow - Business Acquisitions and Disposals

-$33,069,000 (10.54%)

-$36,967,000 (7.58%)

-$40,000,000 (60.00%)

-$100,000,000 (-4900.00%)

Net Cash Flow - Investment Acquisitions and Disposals

-$6,762,000 (26.18%)

-$9,160,000 (90.99%)

-$101,660,000 (0%)

$0 (0%)

Capital Expenditure

-$1,153,000 (-269.55%)

-$312,000 (-81.40%)

-$172,000 (42.28%)

-$298,000 (-14800.00%)

Issuance (Repayment) of Debt Securities

-$15,000,000 (-48.62%)

-$10,093,000 (-404.65%)

-$2,000,000 (93.68%)

-$31,652,000 (-143.00%)

Issuance (Purchase) of Equity Shares

$6,501,000 (106.85%)

-$94,945,000 (-1173.92%)

$8,841,000 (-77.37%)

$39,071,000 (-73.56%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$42,701,000 (36.84%)

$31,206,000 (15.99%)

$26,905,000 (67.06%)

$16,105,000 (210.31%)

Depreciation Amortization & Accretion

$24,112,000 (-1.01%)

$24,359,000 (4.17%)

$23,385,000 (24.12%)

$18,840,000 (84.04%)

HRMY Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

78.10% (-1.39%)

79.20% (-2.10%)

80.90% (-1.10%)

81.80% (-0.97%)

Profit Margin

20.40% (-7.69%)

22.10% (-46.62%)

41.40% (266.37%)

11.30% (128.25%)

EBITDA Margin

32.70% (-14.17%)

38.10% (16.16%)

32.80% (24.71%)

26.30% (2822.22%)

Return on Average Equity (ROAE)

25.20% (-8.36%)

27.50% (-54.24%)

60.10% (148.35%)

24.20% (-38.27%)

Return on Average Assets (ROAA)

16.00% (-4.76%)

16.80% (-47.00%)

31.70% (248.35%)

9.10% (138.08%)

Return on Sales (ROS)

29.30% (-13.57%)

33.90% (23.27%)

27.50% (36.82%)

20.10% (465.45%)

Return on Invested Capital (ROIC)

47.70% (-5.73%)

50.60% (15.53%)

43.80% (42.21%)

30.80% (424.21%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

13.44 (-9.70%)

14.88 (-17.07%)

17.95 (-74.74%)

71.07 (587.53%)

Price to Sales Ratio (P/S)

2.74 (-17.00%)

3.3 (-55.68%)

7.45 (-7.30%)

8.03 (37.72%)

Price to Book Ratio (P/B)

2.98 (-26.51%)

4.05 (-50.07%)

8.11 (-39.31%)

13.37 (-36.83%)

Debt to Equity Ratio (D/E)

0.52 (-30.08%)

0.74 (9.66%)

0.67 (-49.17%)

1.32 (-61.00%)

Earnings Per Share (EPS)

2.56 (17.97%)

2.17 (-29.32%)

3.07 (411.67%)

0.6 (124.19%)

Sales Per Share (SPS)

12.56 (28.37%)

9.79 (32.26%)

7.4 (39.39%)

5.31 (-14.34%)

Free Cash Flow Per Share (FCFPS)

3.84 (4.34%)

3.68 (51.05%)

2.44 (42.80%)

1.71 (1572.41%)

Book Value Per Share (BVPS)

11.59 (47.55%)

7.85 (15.35%)

6.81 (109.99%)

3.24 (-14.03%)

Tangible Assets Book Value Per Share (TABVPS)

15.57 (37.35%)

11.34 (30.81%)

8.67 (72.26%)

5.03 (-51.01%)

Enterprise Value Over EBIT (EV/EBIT)

8 (-11.11%)

9 (-66.67%)

27 (-34.15%)

41 (117.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

7.53 (-5.45%)

7.96 (-64.21%)

22.25 (-28.45%)

31.1 (-97.68%)

Asset Turnover

0.79 (3.55%)

0.76 (-0.78%)

0.77 (-4.61%)

0.8 (34.06%)

Current Ratio

3.31 (20.12%)

2.75 (-45.72%)

5.07 (-4.07%)

5.29 (170.68%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$218,668,000 (-0.19%)

$219,075,000 (51.83%)

$144,294,000 (46.85%)

$98,259,000 (3389.55%)

Enterprise Value (EV)

$1,757,926,930 (-0.37%)

$1,764,401,791 (-44.84%)

$3,198,779,225 (28.18%)

$2,495,590,570 (23.08%)

Earnings Before Tax (EBT)

$191,804,000 (10.62%)

$173,396,000 (65.63%)

$104,686,000 (179.70%)

$37,428,000 (201.31%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$233,412,000 (5.37%)

$221,512,000 (54.11%)

$143,740,000 (79.14%)

$80,238,000 (5203.24%)

Invested Capital

$437,120,000 (11.38%)

$392,465,000 (2.77%)

$381,896,000 (97.44%)

$193,424,000 (101.88%)

Working Capital

$404,170,000 (40.68%)

$287,289,000 (-10.61%)

$321,401,000 (39.34%)

$230,664,000 (79.71%)

Tangible Asset Value

$885,937,000 (31.38%)

$674,340,000 (31.47%)

$512,917,000 (77.16%)

$289,524,000 (9.37%)

Market Capitalization

$1,962,446,930 (3.73%)

$1,891,873,791 (-42.12%)

$3,268,397,225 (31.09%)

$2,493,225,570 (21.23%)

Average Equity

$577,484,000 (23.10%)

$469,134,250 (55.37%)

$301,939,500 (110.79%)

$143,238,750 (187.96%)

Average Assets

$908,175,750 (18.54%)

$766,122,250 (34.03%)

$571,593,250 (50.27%)

$380,370,500 (42.52%)

Invested Capital Average

$438,643,000 (12.63%)

$389,449,750 (41.72%)

$274,794,000 (38.02%)

$199,095,000 (116.49%)

Shares

57,031,297 (-2.63%)

58,571,944 (-1.26%)

59,317,554 (1.45%)

58,471,519 (2.78%)